Concepedia

Z. Boylan

ZB

2

Publications

99

Citations

2

H-Index

2018

Active since

Affiliations

Institute of Cancer Research(Current)

University College London

AstraZeneca (United Kingdom)

Royal Marsden NHS Foundation Trust

King's College London

Z. Boylan is an author at Institute of Cancer Research specializing in radiation oncology, medicine, and cancer therapeutics.

Top concepts

Publications per year

2018–2019

2

Publications

2

PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours

Magnus T. Dillon, Z. Boylan, Deborah A. Smith et al. · Clinical and Translational Radiation Oncology · 2018 · 76 citations · Full text

A phase I study of ATR inhibitor, AZD6738, as monotherapy in advanced solid tumours (PATRIOT part A, B)

Magnus T. Dillon, Jeane Guevara, K. Mohammed et al. · Annals of Oncology · 2019 · 23 citations

, , +6

Rows per page

1–2 of 2